Germany's Merck in advanced talks to acquire US biotech firm SpringWorks
Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...
Exclusive-Germany's Merck in advanced talks to acquire US biotech firm Springworks
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
1GILD : What To Expect When Biotech Giant Gilead Reports Q4 Earnings On Tuesday?
Gilead reports Q4 earnings on Feb. 11. Analysts expect $1.70 EPS. The LEO Pharma deal could reduce 2025 EPS by up to $0.17.
Incyte stock falls 6% amid Q4 earnings, 2025 forecast
Shares of Incyte (INCY) fell 6% Monday after the company released its Q4 earnings report and 2025 sales forecast. Read more ...
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...
Prothena (NASDAQ:PRTA) Price Target Raised to $62.00
Prothena (NASDAQ:PRTA – Free Report) had its price target boosted by Oppenheimer from $58.00 to $62.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the ...
L'Oréal S.A. (LRLCF) Q4 2024 Earnings Conference Call Transcript
Q4 2024 Earnings Conference Call February 7, 2025 3:00 AM ETCompany ParticipantsNicolas Hieronimus - CEOChristophe Babule ...
3,610 Shares in Novavax, Inc. (NASDAQ:NVAX) Bought by Spire Wealth Management
Spire Wealth Management bought a new position in Novavax, Inc. (NASDAQ:NVAX – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...